Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

1,472 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma trial results

Completed

Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00006353

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • British Columbia Cancer Agency - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • British Columbia Cancer Agency Vancouver, British Columbia, Canada
View all 16 locations
View Trial Details
Completed

Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme

NCT00005826

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France
  • Centre Leon Berard Lyon, France
View all 13 locations
View Trial Details
Completed

Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00128700

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Klinikum der Universitaet Regensburg Regensburg, Germany
  • Azienda Ospedaliera di Padova Padova, Italy
  • Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands
View Trial Details
Completed

Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma

NCT00003916

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • Alfred Hospital Melbourne, Victoria, Australia
  • Centre Antoine Lacassagne Nice, France
  • Medizinische Klinik I Dresden, Germany
  • Universitaet Wuerzburg/Hautkrankheiten Würzburg, Germany
View Trial Details
Completed

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

NCT00003293

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
View all 35 locations
View Trial Details
Completed

Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients

NCT01089868

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • Department of Stereotactic Neurosurgery Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • University Hospital Munich, Department of Neurosurgery Munich, Bavaria, Germany
  • University Hospital Bonn, Department of Neurosurgery Bonn, North Rhine-Westphalia, Germany
View Trial Details
Completed

Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection

NCT01240460

Conditions
Astrocytoma, Astrocytoma, Grade IV, Glioblastoma, +8 more
Locations
  • Investigational Site Number 840001 Los Angeles, California, United States
  • Investigational Site Number 840003 San Francisco, California, United States
  • Investigational Site Number 840004 Boston, Massachusetts, United States
  • Investigational Site Number 840002 New York, United States
View Trial Details

Related conditions